Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

141%Other

1.50.890%6.24.538%Total International29.323.326%102.572.641%Total Product Sales$  89.7$  76.917%$  321.5$  265.521%


  • During the fourth quarter of 2012, Cepheid placed a total of 153 GeneXpert systems in its commercial Clinical business.  Additionally, the Company placed a total of 68 GeneXpert systems as part of its High Burden Developing Country (HBDC) program.  For the year ended December 31, 2012, Cepheid placed a total of 523 GeneXpert systems in its commercial Clinical business and an additional 506 GeneXpert systems as part of its HBDC program.  As of December 31, 2012, a cumulative total of 3,835 GeneXpert systems have been placed worldwide.
  • Cash and cash equivalents were $95.8 million as of December 31, 2012.
  • DSO was 43 days.
  • Business OutlookFor the fiscal year ending December 31, 2013, the Company expects:

  • Total revenue to be in the range of $375 to $385 million;
  • Net income to range from a net loss of $(0.05) to net income of $0.01 per share; 
  • Non-GAAP net income in the range of $0.41 to $0.46 per share. 
  • Expected non-GAAP net income excludes approximately $29 million related to stock compensation expense and approximately $4 million related to the amortization of acquired intangibles.  The fully diluted share count for the year is expected to be approximately 72 million, except in the event of a GAAP loss where the share count would be approximately 67 million shares.

    The following table reconciles net income (loss) per share to the non-GAAP net income per share range:Guidance Range for YearEnding December 31, 2013Low HighNet Income (Loss) Per Share$ (0.05)$  0.01Stock Compensation Expense0.400.39Amortization of Purchased Intangible Assets0.060.06Non-GAAP Measure of Net Income Per Share$   0.41$  0.46Accessing Cepheid's Fourth Quarter and Full Year 2012 Results Conference CallThe Com
    '/>"/>

    SOURCE Cepheid
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Cepheid to Webcast Upcoming Financial Presentations
    2. Cepheid Announces Executive Vice President Emerging Markets
    3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    10. Luminex Corporation Reports First Quarter 2012 Results
    11. Hospira Reports First-Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... 31, 2015  AMRI (NASDAQ: AMRI ) ... collaboration focused on the development, manufacture and marketing ... ("APIs"). The collaboration combines Saneca,s strength in extracting ... developing and manufacturing controlled substance APIs with AMRI,s ... processes into these facilities. The collaboration will also ...
    (Date:8/31/2015)... Vascular Ltd., together with its subsidiaries (the "Company" ... the "Group"), a global company engaged in the ... for the minimally invasive treatment of vascular disease, ... ("BTK") cohort of patients in the Chocolate® Balloon ... 15, 2015 at the 5th Annual Amputation Prevention ...
    (Date:8/30/2015)... 31, 2015 Noser Health ... to deliver new platform ... citizen-owned health data transaction platform, announced today strategic partnerships ... to engineer and bring to market its global health ... "Our business model is built on trust, ...
    Breaking Medicine Technology:AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4
    ... 30 AstraZeneca (NYSE:,AZN) today announced that it ... U.S. Food and Drug Administration (FDA) for approval ... Aerosol for the treatment of patients with Chronic ... the long-term,maintenance treatment of asthma in patients 12 ...
    ... Naval Medical Center, George Mason, University Study ... to Baseline Measures and Ongoing ,Surveillance, Model for ... Management of Common, Debilitating Condition, BETHESDA, Md., ... patients for subclinical lymphedema enables clinicians to,establish a ...
    Cached Medicine Technology:AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 2AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 3AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 4AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 5Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema 2Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema 3
    (Date:8/31/2015)... California (PRWEB) , ... August 31, 2015 , ... ... by host/actor/writer/director/ CSUN psychology professor Luciana Lagana (aka Dr. Luciana) received a ... for Best Web Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Wyoming Medical Center, an ... for its Clinical Documentation Improvement (CDI) and medical coding needs. Based on a ... - ezCAC is an enterprise-level coding solution that combines CDI, Coding, Quality and ...
    (Date:8/31/2015)... , ... August 31, 2015 , ... With baseball season ... and the World Series will dominate the sports world. Fans desire nothing more than ... to the final series. For children, especially those who are too young to really ...
    (Date:8/31/2015)... ... 31, 2015 , ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored ... in Mendon, IL. The purpose behind this concert was to raise money for music ... Best Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with a portion of ...
    (Date:8/31/2015)... ... 31, 2015 , ... In preparation for this November’s National Family Caregivers Month, ... sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” The information ... a variety of home healthcare challenges, specifically as they relate to caring for the ...
    Breaking Medicine News(10 mins):Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
    ... that a specialized virus with the ability to reproduce its ... mice and eliminate them. Healthy brain tissue remained virtually untouched, ... of Neuroscience . With more research, the technique could one ... humans. , Most importantly, this study finds that the virus ...
    ... 19 Accenx Technologies, Inc., a,leading company in ... integration solutions, announced today the launch of their,new ... to their,clients, such as large health systems, hospitals, ... physician outreach programs, and connect,physician practices to RyTRAK ...
    ... the daughter of,Virginia Kent, Deceased, seeks vindication in ... which was caused by the prescription drug,Rezulin. Michigan,s ... All Rezulin cases in the United States ... 187 cases from Michigan. All Michigan,cases were dismissed ...
    ... North American Insurance,Leaders, Inc. (Amex: NAO ) ("NAIL"), ... time to consider and vote on the proposed,acquisition of ... of,additional proxies related thereto, its annual meeting of stockholders,originally ... 2:00 p.m. local,time, has been postponed and will now ...
    ... cold winter day and you will see the water vapor ... a Nobel-Prize-related tool, and you could potentially detect trace amounts ... signs of disease. In a new paper,* a team led ... of the National Institute of Standards and Technology (NIST) and ...
    ... development of new technologies that demand a,highly-trained workforce and ... provide the backdrop for this historic,undertaking by the nation,s ... a march, rally and press conference on,Wednesday, Feb. 20 ... gather at the Main Entrance to Summit,Medical Center, 350 ...
    Cached Medicine News:Health News:Tumor-killing virus selectively targets diseased brain cells 2Health News:New Accenx Physician's Relations Department! Now At Your Service 2Health News:Michigan Resident, Kimberly Kent's Drug Product Liability Case Will Be Argued in the United States Supreme Court on February 25, 2008 2Health News:North American Insurance Leaders, Inc. Postpones Stockholders Meeting 2Health News:Optical 'frequency comb' can detect the breath of disease 2Health News:UHW Kicks Off Contract Campaigns for 75,000 Hospital and Nursing Home Workers in Unprecedented Effort to Raise Quality Statewide 2
    ... true breakthrough in ophthalmic ultrasound, offering an ... capability previously unavailable. See pathology formerly unavailable, ... up to 105db to view vitreous details ... 90db setting - or reduce it to ...
    The Ultrasonic BioMicroscope (UBM P40) provides the highest ultrasound resolution for imaging....
    PremierEdge Stab Knives - 45....
    VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
    Medicine Products: